[1]
K. Ivana, D. L. C. Pradana, and C. A. Aprilia, “NARRATIVE REVIEW: COST-EFFECTIVENESS ANALYSIS OF THE USE OF ORAL ANTIDIABETIC DRUGS BIGUANIDE AND SULFONYLUREA GROUP IN PATIENTS WITH TYPE 2 DIABETES MELLITUS”, JRPPS, vol. 1, no. 1, pp. 1–12, Jun. 2022.